A noninvasive blood test
There are many ways to get this genetic information, including methods such as serum screens and diagnostic procedures such as amniocentesis.
As a noninvasive prenatal test, MaterniT 21 PLUS is different from both. It has higher detection rates than serum screening,1 and requires only a blood sample from the mother; amniocentesis requires withdrawing fluid from around the developing baby.
A new NIPT high risk pathway
Introducing MaterniT®21 PLUS with GENOME-Flex. GENOME-Flex is a value-added service that involves the rapid re-sequencing of your original MaterniT 21 PLUS sample using MaterniT GENOME when anomalies are suspected by routine tests later in your pregnancy, such as ultrasounds, without a redraw or diagnostic procedure.
Learn more about MaterniT GENOME-Flex.
If you’ve not had a test and have questions about costs or coverage, use our estimator.
If you have already had a test performed, we can help answer questions about results.
Ask questions about genetic testing options or results, or schedule an appointment.
- Committee on Practice Bulletins—Obstetrics, Committee on Genetics, and Society for Maternal-Fetal Medicine. Screening for fetal aneuploidy. Practice Bulletin No. 163. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2016; 127:e123–37.